Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2619

Actual shortage: 245 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2365 (90%)

Discontinuation Reports

249

To be discontinued: 3 (1%)
Discontinued: 246 (99%)
Reversed: 0 (0%)

Late reports

318 (11%)

Overdue reports

22 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT AMLODIPINE 2.5MG TABLET Resolved 2017-03-17 2017-09-19 3348
ACT AMLODIPINE 5MG TABLET Resolved 2020-11-06 2021-01-07 127998
ACT AMLODIPINE 10MG TABLET Resolved 2020-11-06 2021-01-21 128034
ACT AMLODIPINE 10MG TABLET Resolved 2021-09-30 2021-10-07 146443
ACT AMLODIPINE 5MG TABLET Resolved 2022-12-15 2023-02-16 178518
ACT AMLODIPINE 5MG TABLET Resolved 2023-02-09 2023-04-28 184204
TEVA-AMPHETAMINE XR 3.75MG 3.75MG 3.75MG 3.75MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60068
TEVA-AMPHETAMINE XR 5MG 5MG 5MG 5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-06 2019-01-31 60075
TEVA-AMPHETAMINE XR 6.25MG 6.25MG 6.25MG 6.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61330
TEVA-AMPHETAMINE XR 7.5MG 7.5MG 7.5MG 7.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61333
TEVA-AMPHETAMINE XR 1.25MG 1.25MG 1.25MG 1.25MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2018-12-29 61336
TEVA-AMPHETAMINE XR 2.5MG 2.5MG 2.5MG 2.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-11-30 2019-01-31 68265
TEVA-AMPHETAMINE XR 10MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-03-11 131676
TEVA-AMPHETAMINE XR 15MG CAPSULE (EXTENDED RELEASE) Resolved 2021-01-15 2021-05-06 131679
TEVA-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Resolved 2021-03-25 2021-05-20 136286
TEVA-AMPHETAMINE XR 5MG CAPSULE (EXTENDED RELEASE) Avoided shortage 2021-05-20 2021-07-08 139722
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-15 2021-09-09 142610
TEVA-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2021-09-23 2021-10-14 146092
TEVA-ANASTROZOLE 1MG TABLET Resolved 2020-01-24 2021-01-28 104374
ACT BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2020-01-30 2020-05-29 104930

Showing 1 to 20 of 2619

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598

Showing 81 to 100 of 249